• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: levodopa and carbidopa
Trade Name: Duopa
Date Designated: 01/18/2000
Orphan Designation: Treatment of late stage Parkinson's disease
Orphan Designation Status: Designated/Approved
AbbVie, Inc.
1 N. Waukegan Road
Building AP30-1
North Chicago, Illinois 60064
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: levodopa and carbidopa
Trade Name: Duopa
Marketing Approval Date: 01/09/2015
Approved Labeled Indication: Treatment of motor flucuations in patients with advanced Parkinson's disease
Exclusivity End Date: 01/09/2022 
Exclusivity Protected Indication* :  Treatment of motor flucuations in patients with advanced Parkinson's disease

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-